CINECA IRIS Institutional Research Information System

MASCOLO, ANNAMARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 900
SA - Sud America 531
EU - Europa 134
NA - Nord America 126
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.722
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 416
SG - Singapore 231
VN - Vietnam 225
HK - Hong Kong 143
CN - Cina 133
US - Stati Uniti d'America 100
KR - Corea 96
AR - Argentina 52
IT - Italia 26
FR - Francia 25
ID - Indonesia 25
EC - Ecuador 22
DE - Germania 20
CO - Colombia 15
GB - Regno Unito 12
UA - Ucraina 12
BD - Bangladesh 10
MX - Messico 10
RU - Federazione Russa 10
ZA - Sudafrica 10
CA - Canada 8
IN - India 8
PE - Perù 8
PY - Paraguay 8
IQ - Iraq 7
MA - Marocco 7
CL - Cile 5
EG - Egitto 5
NL - Olanda 5
AZ - Azerbaigian 3
BG - Bulgaria 3
KE - Kenya 3
PL - Polonia 3
SE - Svezia 3
TN - Tunisia 3
TR - Turchia 3
UZ - Uzbekistan 3
VE - Venezuela 3
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
FI - Finlandia 2
JP - Giappone 2
PR - Porto Rico 2
RO - Romania 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.722
Salva come PNG Salva come JPEG
Città #
Hong Kong 143
Seoul 96
Ho Chi Minh City 73
Singapore 63
Hanoi 43
São Paulo 40
Beijing 28
Curitiba 12
Dallas 12
Rio de Janeiro 11
Los Angeles 10
Munich 10
Da Nang 9
Haiphong 8
Porto Alegre 8
Quito 8
Thái Bình 8
Ashburn 7
Belo Horizonte 7
Guayaquil 7
Toronto 7
Biên Hòa 6
Brasília 6
Ha Long 6
Hải Dương 6
London 6
Salvador 6
Can Tho 5
Frankfurt am Main 5
Juiz de Fora 5
Lima 5
Mexico City 5
Recife 5
Brooklyn 4
Buenos Aires 4
Campinas 4
Jakarta 4
Milan 4
Nova Iguaçu 4
Novo Hamburgo 4
Sumaré 4
Asunción 3
Baku 3
Bandung 3
Barbacena 3
Belém 3
Bogotá 3
Bắc Ninh 3
Camaçari 3
Campos dos Goytacazes 3
Cariacica 3
Florence 3
Fortaleza 3
Joinville 3
Karbala 3
Montes Claros 3
Nairobi 3
Nha Trang 3
Ninh Bình 3
Osasco 3
Phủ Lý 3
Resistencia 3
Santa Clara 3
Santo André 3
Serra 3
Sofia 3
Sorocaba 3
St Petersburg 3
Stockholm 3
São José do Rio Preto 3
Tashkent 3
Thái Nguyên 3
Amsterdam 2
Araxá 2
Aversa 2
Baghdad 2
Barueri 2
Bauru 2
Bắc Giang 2
Cabo Frio 2
Cairo 2
Cape Town 2
Catanduva 2
Contagem 2
Cotia 2
Cà Mau 2
Divinópolis 2
Duque de Caxias 2
Durban 2
Erechim 2
Feira de Santana 2
Ferrara 2
Garanhuns 2
General Rodríguez 2
Goiânia 2
Gramado 2
Guapiaçu 2
Guarujá 2
Guarulhos 2
Hortolândia 2
Totale 857
Salva come PNG Salva come JPEG
Nome #
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 42
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 40
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 39
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis 39
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 37
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 36
Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? 36
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database 34
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 34
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 33
Facts and figures of the compassionate use of onco-hematological drugs from 2016 to 2021: Results from the multicentric observational study Compass-O 33
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 33
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 33
Current and future therapeutic perspective in chronic heart failure 33
Neutral endopeptidase (neprilysin) 32
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 31
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database 31
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System 31
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? 30
The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-O 30
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 29
Endotoxin: Structure Source and Effects 29
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 29
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study 28
Antipsychotics and Cardiac Side Effects 28
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 28
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 27
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 26
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study 26
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 25
Safety profile of trastuzumab originator vs biosimilars: a systematic review and meta-analysis of randomized clinical trials 25
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 25
Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study 25
Contribution of Italian Clinical Research for Contrast Media-Induced Nonrenal Adverse Drug Reactions over the Last Three Decades: A Systematic Review 24
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 24
The risk of fractures, acute myocardial infarction, atrial fibrillation and ventricular arrhythmia in geriatric patients exposed to promethazine 24
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review 24
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database 23
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase® 23
Retrospective Analysis of a Real-Life Use of Tixagevimab–Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19 23
Risk of Rhabdomyolysis Associated with Dexmedetomidine Use over the Past 10 Years: Insights from the EudraVigilance Database 23
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta‐blocker use: a Danish nationwide cohort study 22
A case of figurate urticaria by etanercept 22
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 22
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study 22
The efficacy and the safety of Eltrombopag in pediatric patients with Severe Aplastic Anemia: a systematic review 22
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 22
Therapeutic strategies to fight COVID‐19: Which is the status artis? 21
Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature 21
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 21
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 21
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 20
What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials 20
Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System 20
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 20
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 20
Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study 19
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs 19
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 18
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting syste 18
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 18
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 17
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 17
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 17
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting 17
Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study 17
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System 16
Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions 15
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 13
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 13
The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure 13
Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article 12
Relationship Between Gender and the Effectiveness of Montelukast: An Italian/Danish Register-Based Retrospective Cohort Study 10
Totale 1.810
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.775
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025463 0 0 0 6 84 107 40 30 35 23 112 26
2025/20261.347 119 143 368 519 196 2 0 0 0 0 0 0
Totale 1.810